Deprescribing antihypertensive drugs after starting OSA primary therapy?

Revol B, Castelli C, Ben Messaoud R, Coffy A, Bailly S, Jullian-Desayes I, Martinot JB, Martinot P, Joyeux-Faure M, Pépin JL

Open source

DOI
10.1093/sleep/zsac060
Published
2022 May 12
Container
Sleep
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/sleep/zsac060,
  title = {Deprescribing antihypertensive drugs after starting OSA primary therapy?},
  author = {Revol B and Castelli C and Ben Messaoud R and Coffy A and Bailly S and Jullian-Desayes I and Martinot JB and Martinot P and Joyeux-Faure M and Pépin JL},
  year = {2022},
  journal = {Sleep},
  doi = {10.1093/sleep/zsac060},
  url = {https://doi.org/10.1093/sleep/zsac060}
}

RIS

TY  - JOUR
TI  - Deprescribing antihypertensive drugs after starting OSA primary therapy?
AU  - Revol B
AU  - Castelli C
AU  - Ben Messaoud R
AU  - Coffy A
AU  - Bailly S
AU  - Jullian-Desayes I
AU  - Martinot JB
AU  - Martinot P
AU  - Joyeux-Faure M
AU  - Pépin JL
PY  - 2022
JO  - Sleep
DO  - 10.1093/sleep/zsac060
UR  - https://doi.org/10.1093/sleep/zsac060
ER  - 

APA

B, R., C, C., R, B. M., A, C., S, B., I, J., JB, M., P, M., M, J., & JL, P. (2022). Deprescribing antihypertensive drugs after starting OSA primary therapy?. Sleep. https://doi.org/10.1093/sleep/zsac060

Source records